Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Abrdn PLC Director's Dealing 2018

Dec 21, 2018

4853_dirs_2018-12-21_43eea027-0066-4303-b086-920145f45d98.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2894L

Standard Life Aberdeen plc

21 December 2018

Standard Life Aberdeen plc

The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

Standard Life Aberdeen plc ('the Company') has been advised by Link Market Services Trustees Limited that on 20 December 2018, the Trustees of The Standard Life Share Plan purchased ordinary shares of 1361/63 pence each in the Company on the London Stock Exchange at a price of £2.46600 per share on behalf of the executive directors listed below.

Each individual also received free shares from the Company as detailed below in accordance with the share purchase matching commitment under the Share Plan.

Partnership shares acquired Matching shares awarded
Executive Directors
Norman Keith Skeoch 50 20
Roderick Louis Paris 61 20

LEI number of Standard Life Aberdeen plc: 0TMBS544NMO7GLCE7H90

Classification: 3.1. Additional regulated information required to be disclosed under the laws of a Member State

21 December 2018

Enquiries:

Paul McKenna

Deputy Group Company Secretary
+44 (0) 131 245 1168*

* Calls may be monitored and/or recorded to protect both you and us and help with our training. Call charges will vary.

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHBBBDDUXDBGIB